Moffitt Cancer Center Logo
 

Kathleen M. Egan, ScD

Where You Are:
Kathleen M. Egan, ScD

Senior Member

""My chief research focus is the examination of genetic and lifestyle determinants of risk in melanoma, breast cancer and tumors of the brain.""

Office  (813) 745-6803

Education And Training
  • ScD, Harvard University, 1996
  • MPH, Boston University, 1984
  • BS, University of Connecticut, 1979


Dr. Egan is an epidemiologist with interests in basic cancer biology and the molecular genetics of cancer. She has published more than 60 primary research reports in the areas of breast cancer risk factors and outcome; she maintains active collaborations with investigators at Vanderbilt, University of Wisconsin and the Fred Hutchinson Cancer Institute as well as members of the Breast Cancer Association Consortium. Currently, she is funded to investigate genetic and environmental risk factors for glioma, a primary tumor of the brain, and is PI of a clinic-based multicenter case-control study of glioma (‘GliomaSE’) in which Moffitt serves as the coordinating center. Patients with glioma also are followed prospectively for recurrence, progression and mortality endpoints as a basis for outcomes-focused investigation. Dr. Egan is active in postdoctoral research training at Moffitt and currently serves as program leader of an R25T Postdoctoral Training Fellowship in Molecular Epidemiology in the Department of Cancer Epidemiology. 

  • Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA. Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies. Breast Cancer Res Treat. 2014 May;145(1):165-175. Pubmedid: 24647890.
  • Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014 Apr;11(4):203-222. Pubmedid: 24569448.
  • Anic GM, Madden MH, Nabors LB, Olson JJ, Larocca RV, Thompson ZJ, Pamnani SJ, Forsyth PA, Thompson RC, Egan KM. Reproductive factors and risk of primary brain tumors in women. J Neurooncol. 2014 Apr. Pubmedid: 24700240.
  • van de Water W, Bastiaannet E, Egan KM, de Craen AJ, Westendorp RG, Balducci L, van de Velde CJ, Liefers GJ, Extermann M. Management of primary metastatic breast cancer in elderly patients-An international comparison of oncogeriatric versus standard care. J Geriatr Oncol. 2014 Mar. Pubmedid: 24661770.
  • Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Jian G, Rachakonda PS, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, Newton-Bishop J. An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res. 2014 Mar;27(2):234-243. Pubmedid: 24219834.
  • Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Rachakonda PS, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Bishop DT, Newton-Bishop J. Inherited variation in the PARP1 gene and survival from melanoma. Int J Cancer. 2014 Feb. Pubmedid: 24535833.
  • Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA. Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan. Cancer Epidemiol. 2014 Feb;38(1):62-65. Pubmedid: 24373701.
  • Madden MH, Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, Monteiro AN, Egan KM. Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control. 2014 Jan;25(1):25-32. Pubmedid: 24135790.
  • Anic GM, Madden MH, Thompson RC, Nabors LB, Olson JJ, Larocca RV, Browning JE, Brockman JD, Forsyth PA, Egan KM. Toenail iron, genetic determinants of iron status, and the risk of glioma. Cancer Causes Control. 2013 Dec;24(12):2051-2058. Pubmedid: 23996192.
  • Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer. Breast Cancer Res. 2013 Oct;15(5):R99. Pubmedid: 24152546.
  • Anic GM, Madden MH, Sincich K, Thompson RC, Nabors LB, Olson JJ, Larocca RV, Browning JE, Pan E, Egan KM. Early life exposures and the risk of adult glioma. Eur J Epidemiol. 2013 Sep;28(9):753-758. Pubmedid: 23681776.
  • Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, Silva Idos S, Peto J, Humphreys MK, Wang J, Cordina-Duverger E, Menegaux F, Nordestgaard BG, Bojesen SE, Lanng C, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Brauch H, Brüning T, Harth V, The Genica Network , Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Kconfab , Group AM, Lambrechts D, Smeets D, Neven P, Paridaens R, Flesch-Janys D, Obi N, Wang-Gohrke S, Couch FJ, Olson JE, Vachon CM, Giles GG, Severi G, Baglietto L, Offit K, John EM, Miron A, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Chanock SJ, Lissowska J, Liu J, Cox A, Cramp H, Connley D, Balasubramanian S, Dunning AM, Shah M, Trentham-Dietz A, Newcomb P, Titus L, Egan K, Cahoon EK, Rajaraman P, Sigurdson AJ, Doody MM, Guénel P, Pharoah PD, Schmidt MK, Hall P, Easton DF, Garcia-Closas M, Milne RL, Chang-Claude J. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013 Jun;9(3):e1003284. Pubmedid: 23544014. Pmcid: PMC3609648.
  • Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, Hampton JM, Passarelli MN, Willett WC. Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol. 2013 Jun;31(16):1939-1946. Pubmedid: 23569314. Pmcid: PMC3661933.
  • Little RB, Madden MH, Thompson RC, Olson JJ, Larocca RV, Pan E, Browning JE, Egan KM, Nabors LB. Anthropometric factors in relation to risk of glioma. Cancer Causes Control. 2013 May;24(5):1025-1031. Pubmedid: 23456313.
  • Park JY, Amankwah EK, Anic GM, Lin HY, Walls B, Park H, Krebs K, Madden M, Maddox K, Marzban S, Fang S, Chen W, Lee JE, Wei Q, Amos CI, Messina JL, Sondak VK, Sellers TA, Egan KM. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):827-834. Pubmedid: 23462921.
  • Siegel EM, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Han G, Egan KM. Prediagnostic body weight and survival in high grade glioma. J Neurooncol. 2013 May;114(1):79-84. Pubmedid: 23666204.
  • Amankwah EK, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Egan KM. SWI/SNF gene variants and glioma risk and outcome. Cancer Epidemiol. 2013 Apr;37(2):162-165. Pubmedid: 23276717. Pmcid: PMC3578123.
  • Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Menopause. 2013 Mar;20(3):354-358. Pubmedid: 23435034. Pmcid: PMC3549049.
  • Egan KM, Nabors LB, Olson JJ, Monteiro AN, Browning JE, Madden MH, Thompson RC. Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet. 2013 Jan;49(7):420-421. Pubmedid: 22706378. Pmcid: PMC3576847.
  • Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Menopause. 2012 Oct. Pubmedid: 23073182.
  • Higginbotham KS, Breyer JP, McReynolds KM, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Parl FF, Sanders ME, Page DL, Egan KM, Dupont WD, Smith JR. A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1565-1573. Pubmedid: 22806168. Pmcid: PMC3707501.
  • Anic GM, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Madden MH, Reed Murtagh F, Forsyth PA, Egan KM. An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome. Cancer Causes Control. 2012 Sep;23(9):1443-1449. Pubmedid: 22740028. Pmcid: PMC3563063.
  • Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De Vivo I, Nitti D. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012 Jun;104(11):840-854. Pubmedid: 22523397. Pmcid: PMC3611810.
  • Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, O'Neill BP, Buckner JC, Thompson RC, Nabors LB, Olson JJ, Brem S, Madden MH, Browning JE, Wiencke JK, Egan KM, Jenkins RB, Wrensch MR. SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res. 2012 Jun;18(11):3154-3162. Pubmedid: 22472174. Pmcid: PMC3607457.
  • Permuth-Wey J, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Madden MH, Ann Chen Y, Egan KM. A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol. 2012 Mar;105(3):639-646. Pubmedid: 21744077. Pmcid: PMC3217154.
  • Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Slaton J, Anderson JK. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemp Clin Trials. 2012 Mar;33(2):279-285. Pubmedid: 22101219. Pmcid: PMC3268882.
  • Warren Andersen S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-Dietz A. Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat. 2012 Mar;130(3):975-980. Pubmedid: 21769659.
  • Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Anderson K. Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. J Clin Trials. 2012 Jan;2(1). Pubmedid: 24533253. Pmcid: PMC3924733.
  • Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011 Sep;104(2):535-542. Pubmedid: 21203894. Pmcid: PMC3138895.
  • Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Chen YA. Erratum to: Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011 Sep;104(2):543. Pubmedid: 21286782.
  • Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, Holick CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat. 2011 Jul;128(1):229-236. Pubmedid: 21197569. Pmcid: PMC3201727.
  • Higginbotham KS, Breyer JP, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Sanders ME, Page DL, Parl FF, Egan KM, Dupont WD, Smith JR. A multistage association study identifies a breast cancer genetic locus at NCOA7. Cancer Res. 2011 Jun;71(11):3881-3888. Pubmedid: 21610108. Pmcid: PMC3137260.
  • Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A. Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery?. Am J Epidemiol. 2011 May;173(10):1111-1120. Pubmedid: 21430192. Pmcid: PMC3105288.
  • Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren Andersen S, Greenberg ER, Willett WC. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer. 2011 May;117(9):1946-1956. Pubmedid: 21509772. Pmcid: PMC3117094.
  • Cai Q, Wen W, Qu S, Li G, Egan KM, Chen K, Deming SL, Shen H, Shen CY, Gammon MD, Blot WJ, Matsuo K, Haiman CA, Khoo US, Iwasaki M, Santella RM, Zhang L, Fair AM, Hu Z, Wu PE, Signorello LB, Titus-Ernstoff L, Tajima K, Henderson BE, Chan KY, Kasuga Y, Newcomb PA, Zheng H, Cui Y, Wang F, Shieh YL, Iwata H, Le Marchand L, Chan SY, Shrubsole MJ, Trentham-Dietz A, Tsugane S, Garcia-Closas M, Long J, Li C, Shi J, Huang B, Xiang YB, Gao YT, Lu W, Shu XO, Zheng W. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res. 2011 Apr;71(4):1344-1355. Pubmedid: 21303983. Pmcid: PMC3083305.
  • Heine JJ, Land WH, Egan KM. Statistical learning techniques applied to epidemiology: a simulated case-control comparison study with logistic regression. BMC Bioinformatics. 2011 Apr;12:37. Pubmedid: 21272346. Pmcid: PMC3045299.
  • Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Ceballos RM, Titus-Ernstoff L, Egan KM, Holmes MD. Social networks and survival after breast cancer diagnosis. J Cancer Surviv. 2010 Dec;4(4):372-380. Pubmedid: 20652435. Pmcid: PMC2978785.
  • Kim IK, Lane AM, Egan KM, Munzenrider J, Gragoudas ES. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug;117(8):1617-1622. Pubmedid: 20363507.
  • Lane AM, Egan KM, Kim IK, Gragoudas ES. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug;128(8):996-1000. Pubmedid: 20696999.
  • Parl FF, Egan KM, Li C, Crooke PS. Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform. 2010 May;7:109-121. Pubmedid: 19718449. Pmcid: PMC2730178.
  • Anic GM, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Egan KM. Sleep duration and obesity in a population-based study. Sleep Med. 2010 May;11(5):447-451. Pubmedid: 20363668. Pmcid: PMC2854876.
  • Fair AM, Wujcik D, Lin JM, Zheng W, Egan KM, Grau AM, Champion VL, Wallston KA. Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women. J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):71-94. Pubmedid: 20173286. Pmcid: PMC2927817.
  • Lewis TJ, Dupont WD, Egan KM, Jones CD, Disher AC, Riddle WR, Fair AM. The "Got D'ViBE?" study: an inter-institutional project assessing vitamin D and mammographic breast density. J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):17-25. Pubmedid: 20173282. Pmcid: PMC2930256.
  • Peterson NB, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Huang Y, Chanock SJ, Haines JL, Egan KM. Association of COMT haplotypes and breast cancer risk in caucasian women. Anticancer Res. 2010 Jan;30(1):217-220. Pubmedid: 20150638. Pmcid: PMC3086748.
  • Ahern TP, Lash TL, Egan KM, Baron JA. Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control. 2009 Dec;20(10):1837-1844. Pubmedid: 19533391.
  • Lane AM, Egan KM, Harmon D, Holbrook A, Munzenrider JE, Gragoudas ES. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009 Nov;116(11):2206-2212. Pubmedid: 19744725.
  • Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer. 2009 Sep;8(2):109-117. Pubmedid: 18763055.
  • Wise LA, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Trichopoulos D, Hampton JM, Egan KM. Exposure to breast milk in infancy and risk of breast cancer. Cancer Causes Control. 2009 Sep;20(7):1083-1090. Pubmedid: 19330531. Pmcid: PMC3152199.
  • Egan KM. Vitamin D and melanoma. Ann Epidemiol. 2009 Jul;19(7):455-461. Pubmedid: 19282200.
  • Fair AM, Wujcik D, Lin JM, Grau A, Wilson V, Champion V, Zheng W, Egan KM. Obesity, gynecological factors, and abnormal mammography follow-up in minority and medically underserved women. J Womens Health (Larchmt). 2009 Jul;18(7):1033-1039. Pubmedid: 19558307. Pmcid: PMC2851132.
  • Mignone LI, Giovannucci E, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Willett WC, Egan KM. Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer. 2009 Jun;124(12):2929-2937. Pubmedid: 19330841. Pmcid: PMC3564658.
  • Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(5):1403-1409. Pubmedid: 19366908. Pmcid: PMC2715918.
  • Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kämpjärvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schürmann P, Dörk T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5) ...
  • Huang Y, Trentham-Dietz A, García-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM. Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1321-1323. Pubmedid: 19293312. Pmcid: PMC2692636.
  • Newcomb PA, Nichols HB, Beasley JM, Egan K, Titus-Ernstoff L, Hampton JM, Trentham-Dietz A. No difference between red wine or white wine consumption and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):1007-1010. Pubmedid: 19273487. Pmcid: PMC2710299.
  • Kumar N, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Anic G, Egan KM. Tea consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):341-345. Pubmedid: 19124518. Pmcid: PMC3156033.
  • Mignone LI, Giovannucci E, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Orav EJ, Willett WC, Egan KM. Meat consumption, heterocyclic amines, NAT2, and the risk of breast cancer. Nutr Cancer. 2009;61(1):36-46. Pubmedid: 19116874.
  • Peterson NB, Huang Y, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Anic G, Egan KM. Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3284-3287. Pubmedid: 18990773. Pmcid: PMC2674789.
  • Fair AM, Wujcik D, Lin JM, Egan KM, Grau AM, Zheng W. Timing is everything: methodologic issues locating and recruiting medically underserved women for abnormal mammography follow-up research. Contemp Clin Trials. 2008 Sep;29(4):537-546. Pubmedid: 18289943. Pmcid: PMC2483696.
  • Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol. 2008 Aug;168(4):404-411. Pubmedid: 18552361. Pmcid: PMC2727276.
  • Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control. 2008 Aug;19(6):605-613. Pubmedid: 18264784. Pmcid: PMC2729759.
  • Cai H, Shu XO, Egan KM, Cai Q, Long JR, Gao YT, Zheng W. Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women. Pharmacogenet Genomics. 2008 Aug;18(8):657-664. Pubmedid: 18622258. Pmcid: PMC2613759.
  • Newcomb PA, Egan KM, Trentham-Dietz A, Titus-Ernstoff L, Baron JA, Hampton JM, Stampfer MJ, Willett WC. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(4):864-871. Pubmedid: 18381475. Pmcid: PMC2780320.
  • Egan K, Signorello L, Munro H, Hargreaves M, Hollis B, Blot W. Vitamin D insufficiency among African-Americans in the southeastern UnitedStates: implications for cancer disparities (United States). Cancer Causes Control. 2008 Jun;19(5):527-535. Pubmedid: 18219582.
  • Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer. 2008 Jun;98(11):1781-1783. Pubmedid: 18506182. Pmcid: PMC2410126.
  • Holick C, Newcomb P, Trentham-Dietz A, Titus-Ernstoff L, Bersch A, Stampfer M, Baron J, Egan K, Willett W. Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 May;17(2):379-386. Pubmedid: 18250341.
  • Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM. Statin use and risk of breast cancer. Cancer. 2008 Jan;112(1):27-33. Pubmedid: 18008366.
  • Nichols H, Trentham-Dietz A, Egan K, Titus-Ernstoff L, Hampton J, NewcombPA. Oral Contraceptive Use and Risk of Breast Carcinoma In situ. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2262-2268. Pubmedid: 18006914.
  • Trentham-Dietz A, Nichols H, Egan K, Titus-Ernstoff L, Hampton J, NewcombPA. Cigarette Smoking and Risk of Breast Carcinoma In Situ. Epidemiology. 2007 Sep;18(5):629-638. Pubmedid: 17700252.
  • Sprague B, Trentham-Dietz A, Garcia-Closas M, Newcomb P, Titus-Ernstoff L, Hampton J, Chanock S, Haines J, Egan K. Genetic variation in TP53 and risk of breast cancer in a population-based case-control study. Carcinogenesis. 2007 Aug;28(8):1680-6. Pubmedid: 17449902.
  • Liang X, Trentham-Dietz A, Titus-Ernstoff L, Newcomb P, Welch R, HutchinsonAA, Hampton J, Sutcliffe C, Haines J, Egan K. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1610-1614. Pubmedid: 17684135.
  • Gaudet M, Egan K, Lissowska J, Newcomb P, Brinton L, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet. 2007 May;121(3-4):483-490. Pubmedid: 17216494.
  • McElroy J, Egan K, Titus-Ernstoff L, Anderson H, Trentham-Dietz A, Hampton J, Newcomb P. Occupational exposure to electromagnetic field and breast cancer risk in a large, population-based, case-control study in the United States. J Occup Environ Med. 2007 Mar;49(3):266-274. Pubmedid: 17351512.
  • Sprague B, Trentham-Dietz A, Newcomb P, Titus-Ernstoff L, Hampton J, Egan K. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):236-243. Pubmedid: 17301255.
  • Peterson N, Trentham-Dietz A, Newcomb P, Chen Z, Hampton J, Willett W, Egan K. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2006 Nov;119(10):2423-2427. Pubmedid: 16921486.
  • Nichols H, Trentham-Dietz A, Hampton J, Titus-Ernstoff L, Egan K, WillettWC, Newcomb P. From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol. 2006 Nov;164(10):1003-1011. Pubmedid: 16928728.
  • Yasui Y, Newcomb P, Trentham-Dietz A, Egan K. Familial relative risk estimates for use in epidemiologic analyses. Am J Epidemiol. 2006 Oct;164(7):697-705. Pubmedid: 16923773.
  • Garcia-Closas M, Egan K, Newcomb P, Brinton L, Titus-Ernstoff L, ChanockS, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak A, Struewing J. Polymorphisms in DNA double-strand break repair genes and risk of breastcancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet. 2006 May;119(4):376-88. Epub 2. Pubmedid: 16485136.
  • Peterson N, Trentham-Dietz A, Newcomb P, Chen Z, Gebretsadik T, HamptonJM, Stampfer M, Willett W, Egan K. Relation of anthropometric measurements to ovarian cancer risk in apopulation-based case-control study (United States). Cancer Causes Control. 2006 May;17(4):459-467. Pubmedid: 16596298.
  • Egan K. Commentary: sunlight, vitamin D, and the cancer connection revisited. Int J Epidemiol. 2006 Apr;35(2):227-30. Pubmedid: 16303801.
  • Long J, Egan K, Dunning L, Shu X, Cai Q, Cai H, Dai Q, Holtzman J, GaoYT, Zheng W. Population-based case-control study of AhR (aryl hydrocarbon receptor) andCYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics. 2006 Apr;16(4):237-243. Pubmedid: 16538170.
  • Marucci L, Lane A, Li W, Egan K, Gragoudas E, Adams J, Collier J, Munzenrider J. Conservation treatment of the eye: Conformal proton reirradiation for recurrentuveal melanoma. Int J Radiat Oncol Biol Phys. 2006 Mar;64(4):1018-22. Epub 2. Pubmedid: 16376492.
  • Newcomb P, Egan K. Dairy food and ovarian cancer risk. Lancet. 2006 Mar;367(9513):797-799. Pubmedid: 16530561.
  • Zhang Y, Newcomb P, Egan K, Titus-Ernstoff L, Chanock S, Welch R, BrintonLA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breastcancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-358. Pubmedid: 16492928.
  • Egan KM, Sosman JA, Blot WJ. Sunlight and reduced risk of cancer: is the real story vitamin D?. J Natl Cancer Inst. 2005 Feb;97(3):161-163. Pubmedid: 15687354.
  • Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation. 2005 Jan;111(3):334-342. Pubmedid: 15655126.
  • Egan KM, Newcomb PA, Ambrosone CB, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Kimura MT, Nagase H. STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis. 2004 Nov;25(11):2149-2153. Pubmedid: 15271853.
  • Roscoe L, Egan K, Schonwetter R. Creating an academic-community provider partnership in hospice, palliative care, and end-of-life studies. Cancer Control. 2004 Nov;11(6):397-403. Pubmedid: 15625527.
  • Kang JH, Pasquale LR, Willett WC, Rosner BA, Egan KM, Faberowski N, Hankinson SE. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr. 2004 May;79(5):755-764. Pubmedid: 15113712.
  • Egan KM, Thompson PA, Titus-Ernstoff L, Moore JH, Ambrosone CB. MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett. 2003 Sep;199(1):27-33. Pubmedid: 12963120.
  • Kang JH, Pasquale LR, Willett W, Rosner B, Egan KM, Faberowski N, Hankinson SE. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003 Aug;158(4):337-346. Pubmedid: 12915499.
  • Egan KM, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Mignone LI, Farin F, Hunter DJ. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States). Cancer Causes Control. 2003 Feb;14(1):43-51. Pubmedid: 12708724.
  • Fung TT, Spiegelman D, Egan KM, Giovannucci E, Hunter DJ, Willett WC. Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int J Cancer. 2003 Jan;103(1):110-115. Pubmedid: 12455062.
  • Arroyo JG, Postel EA, Stone T, McCuen BW, Egan KM. A matched study of primary scleral buckle placement during repair of posterior segment open globe injuries. Br J Ophthalmol. 2003 Jan;87(1):75-78. Pubmedid: 12488267. Pmcid: PMC1771464.
  • Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1503-1504. Pubmedid: 12433736.
  • Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600. Pubmedid: 12101105.
  • Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002;100:43-48. Pubmedid: 12545676. Pmcid: PMC1358945.
  • McElroy JA, Newcomb PA, Remington PL, Egan KM, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Baron JA, Stampfer MJ, Willett WC. Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology. 2001 Nov;12(6):613-617. Pubmedid: 11679786.
  • Bertone ER, Hankinson SE, Newcomb PA, Rosner B, Willet WC, Stampfer MJ, Egan KM. A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes Control. 2001 Jan;12(1):83-90. Pubmedid: 11227928.
  • Egan KM, Giovannucci E. Dietary mutagens and the risk of breast cancer. J Natl Cancer Inst. 1998 Nov;90(22):1687-1689. Pubmedid: 9827516.
  • Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst. 1996 Jul;88(14):988-993. Pubmedid: 8667430.
  • Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep;333(10):609-614. Pubmedid: 7637720.
  • Bitter GA, Egan KM. Expression of interferon-gamma from hybrid yeast GPD promoters containing upstream regulatory sequences from the GAL1-GAL10 intergenic region. Gene. 1988 Sep;69(2):193-207. Pubmedid: 2853097.
  • Ormerod LD, Egan KM. Spontaneous hyphaema and corneal haemorrhage as complications of microbial keratitis. Br J Ophthalmol. 1987 Dec;71(12):933-937. Pubmedid: 3427003. Pmcid: PMC1041348.
  • Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Bojesen S, Flyger H, Nordestgaard BG, Benítez J, Milne RL, Ignacio Arias J, Zamora MP, Brenner H, Müller H, Arndt V, Rahman N, Turnbull C, Seal S, Renwick A, Brauch H, Justenhoven C, Brüning T, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova N, Antonenkova N, Rogov YI, Karstens JH, Bermisheva M, Prokofieva D, Gantcev SH, Khusnutdinova E, Lindblom A, Margolin S, Chenevix-Trench G, Beesley J, Chen X, Mannermaa A, Kosma VM, Soini Y, Kataja V, Lambrechts D, Yesilyurt BT, Chrisiaens MR, Peeters S, Radice P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton LA, Sherman ME, Lissowska J, Chanock SJ, Hooning M, Martens JW, van den Ouweland AM, Collée JM, Hall P, Czene K, Cox A, Brock IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKa ...
  • Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, Dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J, Investigators K, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ME, ...
  • Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquita HB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ...
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer